Medical References

1. American Cancer Society.
2. Standford, JL, Feng Z, Hamilton As, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: a prostate cancer outcome study
3. Stock RG, Stone NN, Iannuzzi C. Sexual potency following interactive ultrasound-guided brachytherapy for prostate caner. International Journal on Radiation Oncology Biology and Physics. 1996
4. Blasko JC, Wallner K, Grimm PD, Ragde H: Prostate specific antigen based disease control following ultrasound guided 125 iodine implantation for stage T1/T2 prostatic carcinoma. Journal of Urology 1995; 154:1096-1099
5. Trapasso JG, deKernion JB, Smith RB, Dorey F: The incidence and signifi cance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 1994; 152:1821-1825
6. Zagars GK: Prostate-specific cancer antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23:47-53
7. Haakon Ragde, M.D.: Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45- gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinoma. Cancer. 1988; 989-1001